Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
30M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
1.12M
-
Shares change
-
+95.5K
-
Total reported value, excl. options
-
$9.42M
-
Value change
-
+$815K
-
Number of buys
-
14
-
Number of sells
-
-3
-
Price
-
$8.40
Significant Holders of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) as of Q2 2020
19 filings reported holding EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share as of Q2 2020.
EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.12M shares
of 30M outstanding shares and own 3.75% of the company stock.
Largest 10 shareholders include Puissance Capital Management LP (774K shares), VANGUARD GROUP INC (139K shares), Atom Investors LP (75K shares), BlackRock Inc. (46.9K shares), GEODE CAPITAL MANAGEMENT, LLC (26.4K shares), WINTON GROUP Ltd (19.9K shares), BANK OF MONTREAL /CAN/ (18.8K shares), Strategic Wealth Designers (13.6K shares), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main (5.17K shares), and ACADIAN ASSET MANAGEMENT LLC (2.37K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.